COCP vs REG · rev $105.0K vs P/E 34, rev $1.55B
Cocrystal Pharma Inc (COCP) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.
Cocrystal Pharma Inc (COCP) is a biotechnology company listed on US.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Latest reported COCP revenue for 2026-06-30 was $105.0K. Net income was -$3.2M. Revenue was down 53.3% from 2026-03-31 to 2026-06-30. COCP currently screens at market cap $13.3M.
Latest reported REG revenue for 2025-12-31 was $1.55B. Net income was $527.5M. Revenue was up 6.9% from 2024-12-31 to 2025-12-31. REG currently screens at market cap $12.93B and trailing P/E 33.5.
COCP currently screens at market cap $13.3M. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Not investment advice. Open the COCP and REG stock pages for the full models.
Not investment advice.